Compare CDNA & GBDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CDNA | GBDC |
|---|---|---|
| Founded | 1998 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.4B |
| IPO Year | 2007 | 2009 |
| Metric | CDNA | GBDC |
|---|---|---|
| Price | $84.86 | $12.70 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 7 |
| Target Price | ★ $65.33 | $13.63 |
| AVG Volume (30 Days) | 1.3M | ★ 1.3M |
| Earning Date | 10-29-2026 | 11-17-2026 |
| Dividend Yield | N/A | ★ 10.33% |
| EPS Growth | N/A | ★ 4.41 |
| EPS | ★ 2.45 | 0.29 |
| Revenue | ★ $48,324,000.00 | N/A |
| Revenue This Year | $30.36 | N/A |
| Revenue Next Year | $6.23 | N/A |
| P/E Ratio | ★ $33.32 | $43.91 |
| Revenue Growth | ★ 18.93 | N/A |
| 52 Week Low | $14.27 | $11.77 |
| 52 Week High | $73.43 | $14.41 |
| Indicator | CDNA | GBDC |
|---|---|---|
| Relative Strength Index (RSI) | 79.73 | 61.10 |
| Support Level | $17.30 | $12.70 |
| Resistance Level | N/A | $12.97 |
| Average True Range (ATR) | 4.65 | 0.21 |
| MACD | 0.83 | 0.09 |
| Stochastic Oscillator | 80.27 | 88.21 |
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Golub Capital BDC Inc. is an externally managed, closed-end, non-diversified management investment company. Its investment objective is to generate current income and capital appreciation by investing in senior secured and one-stop loans in U.S. middle-market companies. It also invests in second-lien and subordinated loans, warrants, and minority equity securities in U.S. middle-market companies. The company generally invests in securities rated below investment grade by independent rating agencies, or those that would be rated below investment grade if evaluated. The company operates in the USA, Canada, and other countries, with the majority of its revenue coming from the USA.